Equillium partner Biocon reported data from a clinical trial showing that itolizumab significantly decreased mortality in hospitalized COVID-19 patients.

The World Health Organization reported a record increase in global coronavirus cases on Sunday, with the total rising by 230,370 in 24 hours.

A clinical trial of Fujifilm Holdings’ Avigan drug yielded inconclusive results as a treatment of COVID-19, Japanese researchers said on Friday.

The death toll from COVID-19 surpassed half a million people, according to a Reuters tally, a grim milestone for the global pandemic that seems to be resurgent in some countries even as other regions are still grappling with the first wave.

Global coronavirus cases exceeded 10 million on Sunday according to a Reuters tally, marking a major milestone in the spread of the respiratory disease that has so far killed almost half a million people in seven months.

Global cases of the novel coronavirus surpassed 9 million as Brazil and India grappled with a surge in infections while the United States, China and other hard-hit countries reported new outbreaks, according to a Reuters tally.

The European health regulator is looking to fast-track approval of Gilead’s antiviral remdesivir as a potential COVID-19 treatment in Europe.

Global deaths from the novel coronavirus topped 400,000 on Sunday, as case numbers surge in Brazil and India, according to a Reuters tally.

President Donald Trump’s administration awarded a contract worth up to $812 million for a new U.S. company to manufacture drugs and drug ingredients to fight COVID-19 on American soil, aiming to end dependence on other countries.

Favipiravir, a candidate drug for treating the new coronavirus, has produced promising results in early clinical trials in Russia, according to the Russian Direct Investment Fund.